Expanding research capacity and accelerating AIDS vaccine development in Asia.

Simple item page
dc.contributor.authorExcler, Jean-Louisen_US
dc.contributor.authorPitisuttithum, Punneeen_US
dc.contributor.authorRerks-Ngarm, Supachaien_US
dc.contributor.authorShao, Yimingen_US
dc.contributor.authorZhang, Linqien_US
dc.contributor.authorTamashiro, Hikoen_US
dc.contributor.authorOsmanov, Saladinen_US
dc.contributor.author,en_US
dc.date.accessioned2009-05-27T16:08:46Z
dc.date.available2009-05-27T16:08:46Z
dc.date.issued2008-07-09en_US
dc.descriptionThe Southeast Asian Journal of Tropical Medicine and Public Health.en_US
dc.description.abstractAccording to the Joint UN Program on AIDS (UNAIDS), an estimated 4.9 million adults and children are living with HIV in Asia and the Pacific. Refinement and development of existing and new prevention and treatment technologies--including safe, effective, and accessible AIDS vaccines--are urgent public health priorities. The Asian region faces several challenges for AIDS vaccine development. There are multiple genetic variants of HIV-1 driving the epidemic in the region and too few vaccine candidates in the pipeline targeting those subtypes. Low HIV incidence throughout the region means that trial sites must recruit larger numbers of volunteers and shift their focus to higher-risk populations where incidence is higher. Also, the cultural, economic, and political diversity of the region may render collaboration very complex, but also beneficial at a regional level. Recognizing that collaborating as a region could foster and accelerate AIDS vaccine development, participants at the Sapporo International Consultation recommended that an AIDS Vaccine Asian Network (AVAN) be created to facilitate interactions between donors and funding opportunities, increase regional clinical trial and production capacity, support region-specific advocacy and communication strategies, contribute to the Global HIV Vaccine Enterprise Scientific Plan, prepare a regional approach for future vaccine deployment, and develop a regional platform for clinical trials including harmonized legal, regulatory, and ethical frameworks.en_US
dc.description.affiliationInternational AIDS Vaccine Initiative (IAVI), Geneva, Switzerland.en_US
dc.identifier.citationExcler JL, Pitisuttithum P, Rerks-Ngarm S, Shao Y, Zhang L, Tamashiro H, Osmanov S, . Expanding research capacity and accelerating AIDS vaccine development in Asia. The Southeast Asian Journal of Tropical Medicine and Public Health. 2008 Jul; 39(4): 766-84en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/34522
dc.language.isoengen_US
dc.source.urihttps://www.tm.mahidol.ac.th/seameo/2008_39_4/25-4335Meeting.pdfen_US
dc.subject.meshAIDS Vaccinesen_US
dc.subject.meshAsiaen_US
dc.subject.meshBiomedical Researchen_US
dc.subject.meshHIV --immunologyen_US
dc.subject.meshHIV Infections --immunologyen_US
dc.subject.meshHumansen_US
dc.subject.meshInternational Cooperationen_US
dc.subject.meshWorld Healthen_US
dc.titleExpanding research capacity and accelerating AIDS vaccine development in Asia.en_US
dc.typeCongressesen_US
dc.typeResearch Support, Non-U.S. Gov'ten_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
tsajtmph_2008v39n4p766.pdf
Size:
79.89 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Southeast Asian Journal of Tropical Medicine and Public Health